5 active trials 3 recruiting 1 Phase 3 4 disease areas
| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 2 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07211958 | Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute… | Acute Myeloid Leukemias | Recruiting | 2026-07-23 |
| Phase 2 | ||||
| NCT04710576 | A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host… | Chronic Graft-versus-host-disease | Recruiting | 2026-06-16 |
| NCT06132256 | MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis… | Idiopathic Pulmonary Fibrosis | Active, Not Recruiting | 2026-03-27 |
| Phase 1/2 | ||||
| NCT04065399 | A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene… | Acute Myeloid Leukemia | Recruiting | 2026-03-18 |
| Phase 1 | ||||
| NCT06226571 | A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With… | Acute Myeloid Leukemias | Active, Not Recruiting | 2026-06-30 |
Leukemia (3) · Acute Myeloid Leukemia (AML) (3) · Acute Lymphoblastic Leukemia (ALL) (1) · Idiopathic Pulmonary Fibrosis (1)